307 related articles for article (PubMed ID: 15070686)
1. Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells.
Verneris MR; Karimi M; Baker J; Jayaswal A; Negrin RS
Blood; 2004 Apr; 103(8):3065-72. PubMed ID: 15070686
[TBL] [Abstract][Full Text] [Related]
2. Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
Karimi M; Cao TM; Baker JA; Verneris MR; Soares L; Negrin RS
J Immunol; 2005 Dec; 175(12):7819-28. PubMed ID: 16339517
[TBL] [Abstract][Full Text] [Related]
3. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma.
Wu JY; Ernstoff MS; Hill JM; Cole B; Meehan KR
Cytotherapy; 2006; 8(2):141-8. PubMed ID: 16698687
[TBL] [Abstract][Full Text] [Related]
5. Activation of V gamma 9V delta 2 T cells by NKG2D.
Rincon-Orozco B; Kunzmann V; Wrobel P; Kabelitz D; Steinle A; Herrmann T
J Immunol; 2005 Aug; 175(4):2144-51. PubMed ID: 16081780
[TBL] [Abstract][Full Text] [Related]
6. The natural killer-activating receptor, NKG2D, on CD3+CD8+ T cells plays a critical role in identifying and killing autologous myeloma cells.
Talebian L; Fischer DA; Wu J; Channon JY; Sentman CL; Ernstoff MS; Meehan KR
Transfusion; 2014 Jun; 54(6):1515-21. PubMed ID: 24446786
[TBL] [Abstract][Full Text] [Related]
7. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
Gilfillan S; Ho EL; Cella M; Yokoyama WM; Colonna M
Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564
[TBL] [Abstract][Full Text] [Related]
8. NKG2D is a costimulatory receptor for human naive CD8+ T cells.
Maasho K; Opoku-Anane J; Marusina AI; Coligan JE; Borrego F
J Immunol; 2005 Apr; 174(8):4480-4. PubMed ID: 15814668
[TBL] [Abstract][Full Text] [Related]
9. NKG2D stimulation of CD8
Kavazović I; Lenartić M; Jelenčić V; Jurković S; Lemmermann NAW; Jonjić S; Polić B; Wensveen FM
Eur J Immunol; 2017 Jul; 47(7):1123-1135. PubMed ID: 28378389
[TBL] [Abstract][Full Text] [Related]
10. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
Ehrlich LI; Ogasawara K; Hamerman JA; Takaki R; Zingoni A; Allison JP; Lanier LL
J Immunol; 2005 Feb; 174(4):1922-31. PubMed ID: 15699119
[TBL] [Abstract][Full Text] [Related]
11. NKG2D ligation without T cell receptor engagement triggers both cytotoxicity and cytokine production in dendritic epidermal T cells.
Nitahara A; Shimura H; Ito A; Tomiyama K; Ito M; Kawai K
J Invest Dermatol; 2006 May; 126(5):1052-8. PubMed ID: 16484989
[TBL] [Abstract][Full Text] [Related]
12. The role of the NKG2D immunoreceptor in immune cell activation and natural killing.
Jamieson AM; Diefenbach A; McMahon CW; Xiong N; Carlyle JR; Raulet DH
Immunity; 2002 Jul; 17(1):19-29. PubMed ID: 12150888
[TBL] [Abstract][Full Text] [Related]
13. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.
Sutherland CL; Chalupny NJ; Schooley K; VandenBos T; Kubin M; Cosman D
J Immunol; 2002 Jan; 168(2):671-9. PubMed ID: 11777960
[TBL] [Abstract][Full Text] [Related]
14. 4-1BB regulates NKG2D costimulation in human cord blood CD8+ T cells.
Kim YJ; Han MK; Broxmeyer HE
Blood; 2008 Feb; 111(3):1378-86. PubMed ID: 18024793
[TBL] [Abstract][Full Text] [Related]
15. DAP10 contributes to CD8(+) T cell-mediated cytotoxic effector mechanisms during Mycobacterium tuberculosis infection.
Hessmann M; Rausch A; Rückerl D; Adams PS; Simon M; Gilfillan S; Colonna M; Ehlers S; Hölscher C
Immunobiology; 2011 May; 216(5):639-47. PubMed ID: 21122940
[TBL] [Abstract][Full Text] [Related]
16. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
Bauer S; Groh V; Wu J; Steinle A; Phillips JH; Lanier LL; Spies T
Science; 1999 Jul; 285(5428):727-9. PubMed ID: 10426993
[TBL] [Abstract][Full Text] [Related]
17. An activating immunoreceptor complex formed by NKG2D and DAP10.
Wu J; Song Y; Bakker AB; Bauer S; Spies T; Lanier LL; Phillips JH
Science; 1999 Jul; 285(5428):730-2. PubMed ID: 10426994
[TBL] [Abstract][Full Text] [Related]
18. NKG2D receptor signaling enhances cytolytic activity by virus-specific CD8+ T cells: evidence for a protective role in virus-induced encephalitis.
Walsh KB; Lanier LL; Lane TE
J Virol; 2008 Mar; 82(6):3031-44. PubMed ID: 18160433
[TBL] [Abstract][Full Text] [Related]
19. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
Wiemann K; Mittrücker HW; Feger U; Welte SA; Yokoyama WM; Spies T; Rammensee HG; Steinle A
J Immunol; 2005 Jul; 175(2):720-9. PubMed ID: 16002667
[TBL] [Abstract][Full Text] [Related]
20. Regulation of human DAP10 gene expression in NK and T cells by Ap-1 transcription factors.
Marusina AI; Burgess SJ; Pathmanathan I; Borrego F; Coligan JE
J Immunol; 2008 Jan; 180(1):409-17. PubMed ID: 18097042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]